drugset / Trial / NCT01862302

Haloperidol Prophylaxis in Cardiac Surgery for Patients at Risk for Delirium

NCT01862302

Phase 3 Completed 25 enrolled McMaster University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

Will the use of prophylactic Haloperidol for patients undergoing open heart surgery reduce the incidence, duration, and severity of post cardiotomy delirium?

Timeline

Start
2013-08
Primary completion
2015-09
Completion
2016-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Haloperidol Other / unclassified 1 mg
Comparator Haloperidol Other / unclassified 2 mg

Indications

No indication recorded.